Salivary defense proteins: Their network and role in innate and acquired oral immunity

International Journal of Molecular Sciences

Volumn 13, Issue 4, 2012, Pages 4295-4320

  Fábián, Tibor Károly ^a   Hermann, Péter ^a   Beck, Anita ^a   Fejérdy, Pál ^a   Fábián, Gábor ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Acquired; Defense; Immunity; Innate; Oral; Protein; Saliva

Indexed keywords

70 KDA HEAT SHOCK PROTEIN; ADRENOMEDULLIN; ALPHA AMYLASE SALIVA ISOENZYME; AMYLASE; BPI LIKE PROTEIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATIONIC PEPTIDE; CYSTATIN; DEFENSE PROTEIN; DEFENSIN; HEAT SHOCK PROTEIN 70; HISTATIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LACTOFERRIN; LYSOZYME; MUCIN; OZONE; PALATE LUNG AND NASAL EPITHELIAL CLONE PROTEIN; PEPTIDE; PEROXIDASE; PROLINE RICH PROTEIN; PROTEIN BPI; PROTEIN PLUNC; SALIVA PROTEIN; SECRETORY COMPONENT; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; STATHERIN; UNCLASSIFIED DRUG; CATHELICIDIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M;

ADAPTIVE IMMUNITY; AGGLUTINATION TEST; ANTIGEN BINDING; ANTIGEN PRESENTATION; BACTERIUM ADHERENCE; CATALYSIS; CYTOKINE PRODUCTION; DEGRANULATION; GINGIVITIS; HUMAN; INNATE IMMUNITY; MOLECULAR BIOLOGY; MOUTH CAVITY; MOUTH INFLAMMATION; MOUTH MUCOSA; MOUTH ULCER; ORAL WOUND; PHAGOCYTOSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; WOUND; IMMUNOLOGY; SALIVA;

ADAPTIVE IMMUNITY; ADRENOMEDULLIN; CATHELICIDINS; DEFENSINS; HISTATINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; LACTOFERRIN; MOUTH MUCOSA; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR;

EID: 84860204140     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13044295     Document Type: Review

References (128)

1. Fábián, T.K.; Fejérdy, P.; Csermely, P. Salivary genomics, transcriptomics and proteomics: The emerging concept of the oral ecosystem and their use in the early diagnosis of cancer and other diseases. Curr. Genomics 2008, 9, 11-21.
2. Fábián, T.K.; Fejérdy, P.; Csermely, P. Saliva in Health and Disease (Chemical Biology of). In Wiley Encyclopedia of Chemical Biology, 1st ed.; Begley T.P., Ed.; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2008; Volume 4, pp. 1-9.
3. Fábián, T.K.; Fejérdy, P.; Nguyen, M.T.; Soti, C.; Csermely, P. Potential immunological functions of salivary Hsp70 in mucosal and periodontal defense mechanisms. Arch. Immunol. Ther. Exp. 2007, 55, 91-98.
4. Fábián, T.K.; Gótai, L.; Beck, A.; Fábián, T.K.; Fejérdy, P. The role of molecular chaperones (HSPAs/HSP70s) in oral health and oral inflammatory diseases: A review. Eur. J. Inflamm. 2009, 7, 53-61.
5. Madhwani, T.; McBain, A.J. Compositional modification of nascent in vitro dental plaques by human host-defence peptides. FEMS Immunol. Med. Microbiol. 2011, doi:10.1111/j.1574-695X.2011.00922.x.
6. Yao, Y.; Berg, E.A.; Costello, C.E.; Troxler, R.F.; Oppenheim, F.G. Identification of protein components in human acquired enamel pellicle and whole saliva using novel proteomics approaches. J. Biol. Chem. 2003, 278, 5300-5308.
7. Hannig, C.; Hannig, M.; Attin, T. Enzymes in the acquired enamel pellicle. Eur. J. Oral Sci. 2005, 113, 2-13.
8. Lee, J.-Y.; Chung, J.-W.; Kim, Y.-K.; Chung, S.-C.; Kho, H.-S. Comparison of the composition of oral mucosal residual saliva with whole saliva. Oral Dis. 2007, 13, 550-554.
9. Vitorino, R.; Calheiros-Lobo, M.J.; Duarte, J.A.; Domingues, P.M.; Amado, F.M.L. Peptide profile of human acquired enamel pellicle using MALDI tandem MS. J. Sep. Sci. 2008, 31, 523-537.
10. McDonald, E.E.; Goldberg, H.A.; Tabbara, N.; Mendes, F.M.; Siqueira, W.L. Histatin 1 resists proteolytic degradation when adsorbed to hydroxyapatite. J. Dent. Res. 2011, 90, 268-272.
11. Soares, R.V.; Lin, T.; Siqueira, C.C.; Bruno, L.S.; Li, X.; Oppenheim, F.G.; Offner, G.; Troxler, R.F. Salivary micelles: Identification of complexes containing MG2, sIgA, lactoferrin, amylase, glycosylated proline-rich protein and lysozyme. Arch. Oral Biol. 2004, 49, 337-343.
12. Ogawa, Y.; Miura, Y.; Harazono, A.; Kanai-Azuma, M.; Akimoto, Y.; Kawakami, H.; Yamaguchi, T.; Toda, T.; Endo, T; Tsubuki, M.; et al. Proteomic analysis of two types of exosomes in human whole saliva. Biol. Pharm. Bull. 2011, 34, 13-23.
13. Gorr, S.-U. Antimicrobial peptides of the oral cavity. Periodontology 2000 2009, 51, 152-180.
14. Csermely, P.; Ágoston, V.; Pongor, S. The efficiency of multi-target drugs: The network approach might help drug design. Trends Pharmacol. Sci. 2005, 26, 178-182.
15. Vylkova, S.; Li, X.S.; Berner, J.C.; Edgerton, M. Distinct antifungal mechanisms: β-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cystein-free cationic peptides. Antimicrob. Agents Chemoter. 2006, 50, 324-331.
16. Leito, T.D.; Ligtenberg, A.J.M.; Nazmi, K.; Veerman, E.C.I. Identification of salivary components that induce transition of hyphae to yeast in Candida albicans. FEMS Yeast Res. 2009, 9, 1102-1110.
17. White, M.R.; Helmerhorst, E.J.; Ligtenberg, A.; Karpel, M.; Tecle, T.; Siqueira, W.L.; Oppenheim, F.G.; Hartshorn, K.L. Multiple components contribute to ability of saliva to inhibit influenza viruses. Oral Microbiol. Immunol. 2009, 24, 18-24.
18. Brandtzaeg, P. Do salivary antibodies reliably reflect both mucosal and systemic immunity? Ann. NY Acad. Sci. 2007, 1098, 288-311.
19. Bandtzaeg, P.; Korsund, F.R. Significance of different J chain profiles in human tissues: Generation of IgA and IgM with binding site for secretory component is related to the J chain expressing capacity of the total local immunocyte population, including IgG and IgD producing cells, and depends on the clinical state of the tissue. Clin. Exp. Immunol. 1984, 58, 709-718.
20. Kinane, D.F.; Lappin, D.F.; Koulouri, O.; Buckley, A. Humoral immune responses in periodontal disease may have mucosal and systemic immune features. Clin. Exp. Immunol. 1999, 115, 534-541.
21. Mestecky, J.; McGhee, J.R.; Arnold, R.R. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J. Clin. Invest. 1978, 61, 731-737.
22. Proctor, G.B.; Carpenter, G.H.; Segawa, A.; Garrett, J.R.; Ebersole, L. Constitutive secretion of immunoglobulin A and other proteins into lumina of unstimulated submandibular glands in anaesthetized rats. Exp. Physiol. 2003, 88, 7-12.
23. Carpenter, G.H.; Proctor, G.B. Double electrophoretic separation and lectin analyses of the component chains of secretory immunoglobulin A from human saliva. Electrophoresis 2000, 21, 1446-1453.
24. Johansen, F.-E.; Brandtzaeg, P. Transcriptional regulation of the mucosal IgA system. Trends Immunol. 2004, 25, 150-157.
25. Phalipon, A.; Cortésy, B. Novel functions of the polymeric Ig receptor: Well beyond transport of immunoglobulins. Trends Immunol. 2003, 24, 55-58.
26. De Oliveira, I.R.; de Araújo, A.N.; Bao, S.N.; Giugliano, L.G. Binding of lactoferrin and free secretory component to enterotoxigenic Escherichia coli. FEBS Microbiol. Lett. 2001, 203, 29-33.
27. Dallas, S.D.; Rolfe, R.D. Binding of Clostridium difficile toxin A to human milk secretory component. J. Med. Microbiol. 1998, 47, 879-888.
28. Phalipon, A.; Cardona, A.; Kraehenbuhl, J.-P.; Edelman, L.; Sansonetti, P.J.; Corthésy, B. Secretory component: A new role in secretory IgA-mediated immune exclusion in vivo. Immunity 2002, 17, 107-115.
29. Brandtzaeg, P.; Fjellanger, I.; Gjeruldsen, S.T. Adsorption of immunoglobulin A onto oral bacteria in vivo. J. Bacteriol. 1968, 96, 242-249.
30. Shugars, D.C.; Wahl, S.M. The role of the oral environment in HIV-1 transmission. J. Am. Dent. Assoc. 1998, 129, 851-858.
31. Carrero, J.C.; Cervantes-Rebolledo, C.; Aguilar-Diaz, H.; Diaz-Gallardo, M.Y.; Laclette, J.P.; Morales-Montor, J. The role of secretory immune response in the infection by Entamoeba histolytica. Parasite Immunol. 2007, 29, 331-338.
32. Brandtzaeg, P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007, 25, 5467-5484.
33. Wines, B.D.; Hogarth, P.M. IgA receptors in health and disease. Tissue Antigens. 2006, 68, 103-114.
34. Babior, B.M.; Takeuchi, C.; Ruedi, J.; Gutierrez, A.; Wentworth, P., Jr. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. USA 2003, 100, 3031-3034.
35. Wentworth, P., Jr.; Jones, L.H.; Wentworth, A.D.; Zhu, X.; Larsen, N.A.; Wilson, I.A.; Xu, X.; Goddard, W.A., III; Janda, K.; Eschenmoser, A.; et al. Antibody catalysis of the oxidation of water. Science 2001, 293, 1806-1811.
36. Wentworth, P., Jr.; McDunn, J.E.; Wentwoth, A.D.; Takeuchi, C.; Nieva, J.; Jones, T.; Bautista, C.; Ruedi, J.M.; Gutierrez, A.; Janda, K.D.; et al. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 2002, 298, 2195-2199.
37. Nieva, J.; Wentworth, P., Jr. The antibody-catalyzed water oxidation pathway-A new chemical arm to immune defense? Trends Biochem. Sci. 2004, 29, 274-278.
38. Nathan, C. Catalytic antibody bridges innate and adaptive immunity. Science 2002, 298, 2143-2144.
39. Nieva, J.; Kerwin, L.; Wentworth, A.D.; Lerner, R.A.; Wentworth, P., Jr. Immunoglobulins can utilize riboflavin (Vitamin B2) to activate the antibody-catalyzed water oxidation pathway. Immunol. Lett. 2006, 103, 33-38.
40. Yamashita, K.; Miyoshi, T.; Arai, T.; Endo, N.; Itoh, H.; Makino, K.; Mizugishi, K.; Uchiyama, T.; Sasada, M. Ozone production by amino acids contributes to killing of bacteria. Proc. Natl. Acad. Sci. USA 2008, 105, 16912-16917.
41. Fernandez, M.I.; Pedron, T.; Tournebize, R.; Olivo-Marin, J.-C.; Sansonetti, P.J.; Phalipon, A. Anti-inflammatory role for intracellular dimeric immunoglobulin A by neutralization of lipopolysaccharide in epithelial cells. Immunity 2003, 18, 739-749.
42. Asea, A. Stress proteins and initiation of immune response: Chaperokine activity of Hsp70. Exerc. Immunol. Rev. 2005, 11, 34-35.
43. Fábián, T.K.; Gáspár, J.; Fejérdy, P.; Kaán, B.; Bálint, M.; Csermely, P.; Fejérdy, P. Hsp70 is present in human saliva. Med. Sci. Monitor. 2003, 9, BR62-BR65.
44. Fábián, T.K.; Tóth, Z.; Fejérdy, L.; Kaán, B.; Csermely, P.; Fejérdy, P. Photo-acoustic stimulation increases the amount of 70 kDa heat shock protein (Hsp70) in human whole saliva. A pilot study. Int. J. Psychophysiol. 2004, 52, 211-216.
45. Calderwood, S.K.; Mambula, S.S.; Gray, P.J., Jr.; Theriault, J.R. Extracellular heat shock proteins in cell signaling. (Minireview). FEBS Lett. 2007, 581, 3689-3694.
46. Fábián, T.K; Soti, C.; Nguyen, M.T.; Csermely, P.; Fejérdy, P. Expected functions of salivary HSP70 in the oral cavity. In Heat Shock Proteins: New Research, 1st ed.; Morel, E., Vincent, C., Eds.; Nova Science Publishers, Inc.: New York, NY, USA, 2008; pp. 321-340.
47. Anand, P.K.; Anand, E.; Bleck, C.K.E.; Anes, E.; Griffiths, G. Exosomal Hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria. PLoS One 2010, 5, doi:10.1371/journal.pone.0010136.
48. Nguyen, M.T.; Fábián, T.K.; Singh, M.; Csermely, P.; Soti, C. Bacterial binding and opsonizing effect of extracellular Hsp70. (Abstract No: YSF-85). FEBS J. 2008, 275, 460.
49. Campisi, J.; Leem, T.H.; Fleshner, M. Stress-induced extracellular Hsp72 is a functionally significant danger signal to the immune system. Cell Stress Chaperones 2003, 8, 272-286.
50. Multhoff, G. Activation of natural killer cells by heat shock protein 70. Int. J. Hyperth. 2002, 18, 576-585.
51. Prohászka, Z.; Sing, M.; Nagy, K.; Kiss, E.; Lakos, G.; Duba, J.; Füst, G. Heat shock protein 70 is a potent activator of the human complement system. Cell Stress Chaperones 2002, 7, 17-22.
52. Srivastava, P.K. Heat shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2002, 2, 185-194.
53. Cutler, C.W.; Jotwani, R. Dendritic cells at the oral mucosal interface. J. Dent. Res. 2006, 85, 678-689.
54. Ito, H.; Takekoshi, T.; Miyauchi, M.; Ogawa, I.; Takata, T.; Nikai, H.; Takemoto, K. Three-dimensional appearance of Langerhans cells in human gingival epithelium as revealed by confocal laser scanning microscopy. Arch. Oral Biol. 1998, 43, 741-744.
55. Johnson, A.D.; Tytell, M. Exogenous Hsp70 becomes cell associated, but not internalized by stressed arterial smooth muscle cells. In Vitro Cell. Dev. Biol. Anim. 1993, 29, 807-812.
56. Guzhova, I.; Kislyakova, K.; Moskaliova, O.; Fridlanskaya, I.; Tytell, M.; Cheetham, M.; Margulis, B. In vitro studies show that, Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance. Brain Res. 2001, 914, 66-73.
57. Boulanger, J.; Faulds, D.; Eddy, E.M.; Lingwood, C.A. Members of the 70 kDa heat shock protein family specifically recognize sulfoglycolipids: Role in gameterecognition and mycoplasma-related infertility. J. Cell. Physiol. 1995, 165, 7-17.
58. Guzhova, I.V.; Arnoldt, A.C.; Darieva, Z.A.; Kinev, A.V.; Lauskaia, E.B.; Nilsson, K.; Bozhkov, V.M.; Voronin, A.P.; Margulis, B.A. Effects of exogenous stress protein 70 on the functional properties of human promonocytes through binding to cell surface and internalization. Cell Stress Chaperones 1998, 3, 67-77.
59. Asea, A.; Kraeft, S.K.; Kurt-Jones, E.A.; Stevenson, M.A.; Chen, L.B.; Finberg, R.W.; Koo, G.C.; Calderwood, S.K. Hsp70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 2000, 6, 435-442.
60. Asea, A.; Rehli, M.; Kabingu, E.; Boch, J.A.; Bare, O.; Auron, P.E.; Stevenson, M.A.; Calderwood, S.K. Novel signal transduction pathway utilized by extracellular HSP70: Role of toll like receptor (TLR) 2 and TLR4. J. Biol. Chem. 2002, 277, 15028-15034.
61. Li, X.S.; Reddy, M.S.; Baev, D.; Edgerton, M. Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. J. Biol. Chem. 2003, 278, 28553-28561.
62. Li, X.S.; Sun, J.N.; Okamoto-Shibayama, K.; Edgerton, M. Candida albicans cell wall Ssa proteins bind and facilitate import of salivary Histatin 5 required for toxicity. J. Biol. Chem. 2006, 281, 22453-22463.
63. Wiesner, J.; Vilcinskas, A. Antimicrobial peptides. The ancient arm of the human immune system. Virulence 2010, 1, 440-464.
64. Diamond, D.L.; Kimball, J.R.; Krisanaprakornkit, S.; Ganz, T.; Dale, B.A. Detection of beta-defensins secreted by human oral epithelial cells. J. Immunol. Methods 2011, 256, 65-76.
65. Brodgen, K.A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005, 3, 238-250.
66. Jenssen, H.; Hamill, P.; Hancock, R.E. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006, 19, 491-511.
67. Johnson, D.A.; Yeh, C.K.; Dodds, M.W.J. Effect of donor age on the concentration of histatins in human parotid and submandibular/sublingual saliva. Arch. Oral Biol. 2000, 45, 731-740.
68. Oudhoff, M.J.; Bolscher, J.G.; Nazmi, K.; Kalay, H.; van't Hof, W.; Nieuw Amerongen, A.V.; Veerman, E.C.I. Histatins are the major wound-closure stimulating factors in human saliva as identified in cell culture assay. FASEB J. 2008, 22, 3805-3812.
69. Grogan, J.; McKnight, C.J.; Troxler, R.F.; Oppenheim, F.G. Zinc and copper bind to unique sites of histatin 5. FEBS Lett. 2001, 491, 76-80.
70. Gusman, H.; Travis, J.; Helmerhorst, E.J.; Potempa, J.; Troxler, R.F.; Oppenheim, F.G. Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease. Infect. Immun. 2001, 69, 1402-1408.
71. Nishikata, M.; Kanehira, T.; Oh, H.; Tani, H.; Tazaki, M.; Kuboki, Y. Salivary hystatin as an inhibitor of protease produced by the oral bacterium Bacteroides gingivalis. Biochem. Biophys. Res. Comm. 1991, 174, 625-630.
72. Shimotoyodome, A.; Kobayashi, H.; Tokimitsu, I.; Matsukobo, T. Statherin and histatin 1 reduce parotid saliva promoted Streptococcus mutans strain MT8148 adhesion to hydroxyapatite surfaces. Caries. Res. 2006, 40, 403-411.
73. Bennick, A. Interaction of plant polyphenols with salivary proteins. Crit. Rev. Oral Biol. Med. 2002, 13, 184-196.
74. Van der Kraan, M.I.; Groenink, J.; Nazmi, K.; Veerman, E.C.; Bolscher, J.G.; Nieuw Amerongen, A.V. Lactoferrampin: A novel antimicrobial peptide in the N-1-domain of bovine lactoferrin. Peptides 2004, 25, 177-183.
75. Bolscher, J.G.; Adao, R.; Nazmi, K.; van der Keybus, P.A.; van't Hof, W.; Nieuw Amerongen, A.V.; Bastos, M.; Veerman, E.C.I. Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides. Biochimie 2009, 91, 123-132.
76. Välimaa, H.; Tenovuo, J.; Waris, M.; Hukkanen, V. Human lactoferrin but not lysozyme neutralizes HSV-I and inhibits HSV-I replication and cell-to-cell spread. Virol. J. 2009, 6, 53.
77. Boman, H.G. Antibacterial peptides: Basic facts and emerging concepts. J. Intern. Med. 2003, 254, 197-215.
78. Heilborn, J.D.; Nilsson, M.F.; Kratz, G.; Weber, G.; Sorensen, O.; Borregaard, N.; Stale-Backdahl, M. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 2003, 120, 379-389.
79. Moreau, T.; Baranger, K.; Dadé, S.; Dallet-Choisy, S.; Guyot, N.; Zani, M.L. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie 2008, 90, 284-295.
80. Jana, N.K.; Gray, L.R.; Shugars, D.C. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: A role of SLPI in innate mucosal immunity. J. Virol. 2005, 79, 6432-6440.
81. Williams, S.E.; Brown, T.I.; Roghanian, A.; Sallenave, J.-M. SLPI and elafin: One glove, many fingers. Clin. Sci. 2006, 110, 21-35.
82. Gröschl, M.; Wendler, O.; Topf, H.-G.; Bohlender, J.; Köhler, H. Significance of salivary adrenomedullin in the maintenance of oral health: Stimulation of oral cell proliferation and antibacterial properties. Regul. Peptides 2009, 154, 16-22.
83. Kapas, S.; Bansal, A.; Bhargava, V.; Maher, R.; Malli, D.; Hagi-Pavli, E.; Allaker, R.P. Adrenomedullin expression in pathogen-challenged oral epithelial cells. Peptides 2001, 22, 1485-1489.
84. Allaker, R.P.; Kapas, S. Adrenomedullin and mucosal defense: Interaction between host and microorganism. Regul. Peptides 2003, 112, 147-152.
85. Allaker, R.P.; Grosvenor, P.W.; McAnerney, D.C.; Sheehan, B.E.; Srikanta, B.H.; Pell, K.; Kapas, S. Mechanisms of adrenomedullin antimicrobial action. Peptides 2006, 27, 661-666.
86. Veerman, E.C.; van den Keybus, P.A.; Vissink, A.; Nieuw Amerongen, A.V. Human glandular salivas: Their separate collection and analysis. Eur. J. Oral Sci. 1996, 104, 346-352.
87. Laible, N.J.; Germaine, G.R. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: Inhibition by chitin oligosaccharides. Infect. Immun. 1985, 48, 720-728.
88. Ibrahim, H.R.; Thomas, U.; Pellegrini, A. A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permabilization action. J. Biol. Chem. 2001, 276, 43767-43774.
89. Marquis, G.; Garzon, S.; Strykowski, H.; Auger, P. Cell walls of normal and lysozyme-damaged blastoconidia of Candida albicans: Localization of surface factor 4 antigen and vicinal-glycol staining. Infect. Immun. 1991, 59, 1312-1318.
90. Lee-Huang, S.; Huang, P.L.; Sun, Y.; Huang, P.L.; Kung, H.-F.; Blithe, D.L.; Chen, H.-C. Lysozyme and RNases as anti-HIV components in β-core preparations of human chorionic gonadotropin. Proc. Natl. Acad. Sci. USA 1999, 96, 2678-2681.
91. Sava, G.; Benetti, A.; Ceschia, V.; Pacor, S. Lysozyme and cancer: Role of exogenous lysozyme as anticancer agent (review). Anticancer Res. 1989, 9, 583-591.
92. Choi, S.; Baik, J.E.; Jeon, J.H.; Cho, K.; Seo, D.-G.; Kum, K.-Y.; Yun, C.-H.; Han, S.H. Identification of Porphiromonas gingivalis lipopolysaccharide-binding proteins in human saliva. Mol. Immunol. 2011, 48, 2207-2213.
93. Gasior-Chrzan, B.; Falk, E.S. Lysozyme and IgA concentrations in serum and saliva from psoriatic patients. Acta Derm. Venereol. (Stockh.) 1992, 72, 138-140.
94. Geetha, C.; Venkatesh, S.G.; Dunn, B.H.; Gorr, S.U. Expression of anti-bacterial activity of human parotid secretory protein (PSP). Biochem. Soc. Trans. 2003, 31, 815-818.
95. Shiba, H.; Venkatesh, S.G.; Gorr, S.U.; Barbieri, G.; Kurihara, H.; Kinane, D.F. Parotid secretory protein is expressed and inducible in human gingival keratinocytes. J. Periodontal Res. 2005, 40, 153-157.
96. Vargas, P.A.; Speight, P.M.; Bingle, C.D.; Barrett, A.W.; Bingle, L. Expression of PLUNC family members in benign and malignant salivary gland tumors. Oral Dis. 2008, 14, 613-619.
97. Bosch, J.A.; Veerman, E.C.I.; de Geus, E.J.; Proctor, G.B. α-Amylase as a reliable and convenient measure of sympathetic activity: Don't start salivating just yet! Psychoneuroendocrinology 2011, 36, 449-453.
98. Scannapieco, F.A.; Torres, G.; Levine, M.J. Salivary α-amylase: Role in dental plaque and caries formation. Crit. Rev. Oral Biol. Med. 1993, 4, 301-307.
99. Vitorino, R.; Lobo, M.J.C.; Ferrer-Correira, A.; Dubin, J.R.; Tomer, K.B.; Domingues, P.M.; Amado, M.L. Identification of human whole saliva protein components using proteomics. Proteomics 2004, 4, 1109-1115.
100. Scannapieco, F.A.; Torres, G.; Levine, M.J. Salivary amylase promotes adhesion of oral streptococci to hydroxyapatite. J. Dent. Res. 1995, 74, 1360-1366.
101. Rogers, J.D.; Palmer, R.J.; Kolenbrander, P.E.; Scannapieco, F.A. Role of Streptococcus gordonii amylase-binding protein A in adhesion to hydroxyapatite, starch metabolism, and biofilm formation. Infect. Immun. 2001, 69, 7046-7056
102. Okahashi, N.; Nakata, M.; Terao, Y.; Isoda, R.; Sakurai, A.; Sumitomo, T.; Yamaguchi, M.; Kimura, R.K.; Oiki, E.; Kawabata, S.; Ooshima, T. Pili of oral Streptococcus sanguinis bind to salivary amylase and promote the biofilm formation. Microb. Pathog. 2011, 50, 148-154.
103. Mellersh, A.; Clark, A.; Hafiz, S. Inhibition of Neisseria gonorrhoeae by normal human saliva. Br. J. Ven. Dis. 1979, 55, 20-23.
104. Sato, K.; Tokuhisa, S.; Inaba, Y. Effect of enzymes on the growth of human and animal rotaviruses. J. Vet. Med. Sci. 1995, 57, 569-570.
105. Dickinson, D.P. Salivary (SD-type) cystatins: Over one billion years in making-But to what purpose? Crit. Rev. Oral Biol. Med. 2002, 13, 485-508.
106. Blankenvoorde, M.F.; Henskens, Y.M.; van der Weijden, G.A.; van den Keijbus, P.A.; Veerman, E.C.; Nieuw Amerongen, A.V. Cystatin A in gingival crevicular fluid of periodontal patients. J. Periodontal Res. 1997, 32, 583-588.
107. Blankenvoorde, M.F.; van't Hof, W.; Walgreen-Weterings, E.; vanSteenbergen, T.J.; Brand, H.S.; Veerman, E.C.; Nieuw-Amerongen, A.V. Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphiromonas gingivalis. Biol. Chem. 1998, 379, 1371-1375.
108. Schwartz, S.S.; Zhu, W.X.; Sreebny, L.M. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis of human whole saliva. Arch. Oral Biol. 1995, 40, 949-958.
109. Tenovuo, J. Antimicrobial agents in saliva. Protection for the whole body. J. Dent. Res. 2002, 81, 807-809.
110. Chang, W.-I.; Chang, J.-Y.; Kim, Y.-Y.; Lee, G.; Kho, H.S. MUC1 expression in the oral mucosal epithelial cells of the elderly. Arch. Oral Biol. 2011, 56, 885-890.
111. Denny, P.C.; Denny, P.A.; Klauser, D.K.; Hong, S.H.; Navazesh, M.; Tabak, L.A. Age related changes in mucins from hguman whole saliva. J. Dent. Res. 1991, 70, 1320-1327.
112. Veerman, E.C.I.; Valentijl-Benz, M.; van den Keybus, P.A.M.; Rathman, W.M.; Sheehan, J.K.; Nieuw Amerongen, A.V. Immunochemical analysis of high molecular-weight human salivary mucins (MG1) using monoclonal antibodies. Arch. Oral Biol. 1991, 36, 923-932.
113. Pramanik, R.; Osalian, S.M.; Challacombe, S.J.; Urquhart, D.; Proctor, G.B. Protein and mucin retention on oral mucosal surfaces in dry mouth patients. Eur. J. Oral Sci. 2010, 118, 245-253.
114. Lis, M.; Liu, T.T.; Barker, K.S.; Rogers, P.D.; Bobek, L.A. Antimicrobial peptide MUC7 12-mer activates the calcium/calcineurin pathways of Candida albicans. FEMS Yeast Res. 2010, 10, 579-586.
115. Ihalin, R.; Loimaranta, V.; Tenovuo, J. Origin, structure, and biological activities of peroxidases in human saliva. Arch. Biochem. Biophys. 2006, 445, 261-268.
116. Welk, A.; Meller, CH.; Schubert, R.; Schwahn, C.; Kramer, A.; Below, H. Effect of lactoperoxidase on the antimicrobial effectiveness of the thiocyanate hydrogen peroxide combination in a quantitative suspension test. BMC Microbiol. 2009, 9, doi:10.1186/1471-2180-9-134.
117. Ashby, M.T. Inorganic chemistry of defensive peroxidases in the human oral cavity. J. Dent. Res. 2008, 87, 900-914.
118. Geiszt, M.; Witta, J.; Baffi, J.; Lekstrom, K.; Leto, T.L. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 2003, 17, 1502-1504.
119. Rada, B.; Leto, T.L. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib. Microbiol. 2008, 15, 164-187.
120. Jensen, J.L.; Lamkin, M.S.; Troxler, R.F.; Oppenheim, F.G. Multiple forms of atatherin in human salivary secretions. Arch. Oral Biol. 1991, 36, 529-534.
121. Schwartz, S.S.; Hay, D.I.; Schluckebier, S.K. Inhibitio of calcium phosphate precipitation by human salivary statherin: Structure-activity relationships. Calcif. Tissue Int. 1992, 50, 511-517.
122. Proctor, G.B.; Hamdan, S.; Carpenter, G.H.; Wilde, P. A statherin and calcium enriched layer at the air interface of human parotod saliva. Biochem. J. 2005, 389, 111-116.
123. Ligtenberg, A.J.; Veerman, E.C.; Nieuw Amerongen, A.V.; Mollenhauer, J. Salivary agglutinin/glycoprotein-340/DMBT1: A single molecule with variable composition and with different functions in infection, inflammation and cancer. Biol. Chem. 2007, 388, 1275-1289.
124. Hartshorn, K.L.; Ligtenberg, A.; White, M.R.; van Eijk, M.; Hartshorn, M.; Pemperton, L.; Holmskov, U.; Crouch, E. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem. J. 2006, 393, 545-553.
125. Edwards, A.M.; Manetti, A.G.O.; Falugi, F.; Zingaretti, C.; Capo, S.; Buccato, S.; Bensi, G.; Telford, J.L.; Margarit, I.; Grandi, G. Scavenger receptor gp340 aggregates group A streptococci by binding pili. Mol. Microbiol. 2008, 68, 1378-1394.
126. Malamud, D.; Abrams, W.R.; Barber, C.A.; Weissman, D.; Rehtanz, M.; Golub, E. Antiviral activities in human saliva. Adv. Dent. Res. 2011, 23, 34-37.
127. Corbin, B.D.; Seeley, E.H.; Raab, A.; Feldmann, J.; Miller, M.R.; Torres, V.J.; Anderson, K.L.; Dattilo, B.M.; Dunman, P.M.; Gerads, R., et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 2008, 319, 962-965.
128. Kido, J.; Nakamura, T.; Kido, R.; Ohishi, K.; Yamauchi, N.; Kataoka, M.; Nagata, T. Calprotectin in gingival crevicular fluid correlated with clinical and biochemical markers of periodontal disease. J. Clin. Periodontol. 1999, 26, 653-657.